Disorders of the gut-brain interaction (DGBI) are characterized by gastrointestinal symptoms resulting from a combination of various factors—including motility disorders, visceral hypersensitivity, and dysbiosis. For many years, research into and clinical management of GBI have been based on diagnostic criteria published by the Rome Foundation. The Rome V criteria, published in 2026, provide a comprehensive overview of the current evidence-based knowledge, with a focus on changes from the previous version (Rome IV).
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Psychedelic-assisted therapy
Current status of PAT
- First-line treatment for T2D
SGLT2i, metformin, or both?
- Biophilic Design of Work Environments
Effects on Health, Well-Being, and Productivity
- From symptom to diagnosis
Intrapelvic mass with an ambiguous differential diagnosis
- Endocrinology: APECED-Associated Hypoparathyroidism
A parathyroid hormone analog corrected serum calcium levels
- Transient ischemic attack
Comprehensive diagnostic testing can reduce the risk of stroke
- Malignant Tumors of the Clavicle
Surgical Challenges and Recurrence Patterns
- Chronic hand eczema: common, long-lasting, and distressing